Elective Intubation Indications for Guillain‑Barré Syndrome in the Emergency Department

Respiratory Criteria for Elective Intubation

Patients with Guillain‑Barré syndrome should be intubated electively when vital capacity falls below 15–20 mL kg⁻¹, maximal inspiratory pressure is under 30 cmH₂O, or they cannot count to 15 breaths in a single respiratory effort, to prevent acute respiratory failure. 1
Inability to count to 15 (or ≤19) breaths in one breath is the most ominous clinical sign of impending respiratory failure. 1
Resting dyspnea or dyspnea while speaking, use of accessory respiratory muscles, and tachypnea or tachycardia are additional warning signs. 1
The “20/30/40” rule (vital capacity < 20 mL kg⁻¹ or < 1 L, maximal inspiratory pressure < 30 cmH₂O, maximal expiratory pressure < 40 cmH₂O, or > 30 % reduction in any parameter) strongly predicts the need for mechanical ventilation. 1

Rapid progression of weakness (onset to admission < 7 days), bulbar dysfunction (e.g., dysphagia, reduced gag reflex), bilateral facial weakness, and dysautonomia (arrhythmias, marked blood‑pressure swings) independently predict respiratory failure and warrant intensive monitoring. 1

The Erasmus GBS Respiratory Insufficiency Score (EGRIS) estimates a 1‑90 % probability of requiring mechanical ventilation within one week and should be used to triage patients to the ICU. 1

Approximately 30 % of patients with Guillain‑Barré syndrome develop respiratory failure, and 22 % require mechanical ventilation during the first week of illness. 1

Failure to lift the arms off the bed one week after intubation and an axonal electrophysiological subtype or inexitable nerves are associated with prolonged mechanical ventilation, supporting consideration of early tracheostomy (within 14 days). 1

A modified rapid sequence induction (SIR) protocol is recommended for elective intubation in Guillain‑Barré patients. 2
Ketamine is the preferred induction agent for hemodynamically unstable patients. 3
Rocuronium 1.0–1.2 mg kg⁻¹ is the neuromuscular blocker of choice; succinylcholine should be avoided after 24 h from disease onset due to hyperkalaemia risk. 4
Sugammadex should be immediately available to reverse rocuronium blockade if needed. 4
Optimal pre‑oxygenation with CPAP or non‑invasive ventilation is advised for hypoxemic patients. 3
Performing intubation with the patient in a head‑up position improves airway visualization. 2
First‑line use of a videolaryngoscope increases first‑attempt success rates. 3
Cricoid pressure may be applied but should be released if it hinders laryngoscopy. 3
Confirmation of tube placement with end‑tidal CO₂ waveform capnography is required. 3

The inability to count to 15 (or ≤19) in a single breath is the most ominous bedside physical sign for imminent respiratory failure in Guillain-Barré syndrome, as recommended by the American Academy of Neurology 5, 6

The single breath count test directly correlates with vital capacity and predicts the need for mechanical ventilation, with each counted number approximately equal to 116 mL of vital capacity, according to the American Thoracic Society 6
A count of ≤19 specifically predicts the requirement for mechanical ventilation and should trigger immediate ICU admission and preparation for intubation, as suggested by the Neurocritical Care Society 6, 7
The "20/30/40 rule" for objective measurements identifies patients at imminent risk: vital capacity <20 mL/kg, maximum inspiratory pressure <30 cmH₂O, and maximum expiratory pressure <40 cmH₂O, as defined by the American College of Chest Physicians 6, 7, 8

Do not rely on pulse oximetry or arterial blood gases as early indicators of respiratory failure, as stated by the Centers for Disease Control and Prevention 9, 10

Immediate ICU admission is necessary when the single breath count is ≤19 or ≤15, or when other ominous signs are present, as recommended by the Society of Critical Care Medicine 5, 11, 7
Initiate immunotherapy immediately (IVIg 0.4 g/kg/day for 5 days), as suggested by the American Academy of Neurology 5, 11, 7
Serial monitoring every 2-4 hours of respiratory function is crucial, according to the American Thoracic Society 6, 7

Up to 30% of GBS patients develop respiratory failure requiring mechanical ventilation, and 22% require it within the first week of admission, as reported by the American Academy of Neurology 5, 11